Barbados

Barbados

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.43 (0.35 - 0.50) 2019 Modelled IHME
0.43 (0.35 - 0.50) 2018 Modelled IHME
0.43 (0.36 - 0.51) 2017 Modelled IHME
0.44 (0.36 - 0.50) 2016 Modelled IHME
0.44 (0.37 - 0.50) 2015 Modelled IHME
0.44 (0.37 - 0.50) 2014 Modelled IHME
0.45 (0.38 - 0.51) 2013 Modelled IHME
0.46 (0.38 - 0.53) 2012 Modelled IHME
0.47 (0.39 - 0.54) 2011 Modelled IHME
0.48 (0.39 - 0.55) 2010 Modelled IHME
0.49 (0.40 - 0.56) 2009 Modelled IHME
0.49 (0.41 - 0.57) 2008 Modelled IHME
0.5 (0.42 - 0.58) 2007 Modelled IHME
0.51 (0.42 - 0.59) 2006 Modelled IHME
0.51 (0.42 - 0.59) 2005 Modelled IHME
0.51 (0.42 - 0.59) 2004 Modelled IHME
0.51 (0.42 - 0.60) 2003 Modelled IHME
0.51 (0.42 - 0.60) 2002 Modelled IHME
0.52 (0.42 - 0.60) 2001 Modelled IHME
0.52 (0.42 - 0.60) 2000 Modelled IHME
0.52 (0.43 - 0.60) 1999 Modelled IHME
0.53 (0.44 - 0.61) 1998 Modelled IHME
0.54 (0.45 - 0.62) 1997 Modelled IHME
0.55 (0.45 - 0.63) 1996 Modelled IHME
0.55 (0.45 - 0.64) 1995 Modelled IHME
0.55 (0.45 - 0.64) 1994 Modelled IHME
0.55 (0.45 - 0.64) 1993 Modelled IHME
0.55 (0.45 - 0.64) 1992 Modelled IHME
0.54 (0.45 - 0.64) 1991 Modelled IHME
0.54 (0.44 - 0.64) 1990 Modelled IHME
1.03 (0.08 - 12.06) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.02 - 0.05) 2019 Modelled IHME
0.03 (0.02 - 0.05) 2018 Modelled IHME
0.04 (0.02 - 0.05) 2017 Modelled IHME
0.03 (0.02 - 0.05) 2016 Modelled IHME
0.03 (0.02 - 0.05) 2015 Modelled IHME
0.04 (0.03 - 0.05) 2014 Modelled IHME
0.04 (0.03 - 0.06) 2013 Modelled IHME
0.05 (0.03 - 0.07) 2012 Modelled IHME
0.06 (0.04 - 0.07) 2011 Modelled IHME
0.06 (0.04 - 0.08) 2010 Modelled IHME
0.06 (0.04 - 0.08) 2009 Modelled IHME
0.06 (0.04 - 0.08) 2008 Modelled IHME
0.06 (0.04 - 0.08) 2007 Modelled IHME
0.06 (0.04 - 0.08) 2006 Modelled IHME
0.06 (0.04 - 0.08) 2005 Modelled IHME
0.06 (0.04 - 0.09) 2004 Modelled IHME
0.08 (0.05 - 0.10) 2003 Modelled IHME
0.1 (0.07 - 0.13) 2002 Modelled IHME
0.12 (0.08 - 0.16) 2001 Modelled IHME
0.14 (0.10 - 0.20) 2000 Modelled IHME
0.17 (0.12 - 0.23) 1999 Modelled IHME
0.21 (0.15 - 0.28) 1998 Modelled IHME
0.26 (0.18 - 0.33) 1997 Modelled IHME
0.29 (0.20 - 0.38) 1996 Modelled IHME
0.3 (0.21 - 0.40) 1995 Modelled IHME
0.3 (0.21 - 0.40) 1994 Modelled IHME
0.3 (0.21 - 0.40) 1993 Modelled IHME
0.3 (0.21 - 0.40) 1992 Modelled IHME
0.3 (0.21 - 0.39) 1991 Modelled IHME
0.3 (0.21 - 0.40) 1990 Modelled IHME
0.34 (0.02 - 4.81) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.04 (1.50 - 2.67) 2019 Modelled IHME
1.95 (1.46 - 2.53) 2018 Modelled IHME
1.89 (1.41 - 2.48) 2017 Modelled IHME
1.84 (1.39 - 2.40) 2016 Modelled IHME
1.8 (1.38 - 2.34) 2015 Modelled IHME
1.79 (1.38 - 2.30) 2014 Modelled IHME
1.79 (1.39 - 2.29) 2013 Modelled IHME
1.81 (1.43 - 2.31) 2012 Modelled IHME
1.86 (1.47 - 2.36) 2011 Modelled IHME
1.91 (1.51 - 2.41) 2010 Modelled IHME
1.99 (1.56 - 2.53) 2009 Modelled IHME
2.15 (1.69 - 2.73) 2008 Modelled IHME
2.28 (1.77 - 2.89) 2007 Modelled IHME
2.38 (1.86 - 3.02) 2006 Modelled IHME
2.39 (1.88 - 3.03) 2005 Modelled IHME
2.39 (1.88 - 3.02) 2004 Modelled IHME
2.38 (1.88 - 3.01) 2003 Modelled IHME
2.33 (1.84 - 2.94) 2002 Modelled IHME
2.27 (1.79 - 2.85) 2001 Modelled IHME
2.37 (1.87 - 2.99) 2000 Modelled IHME
2.44 (1.92 - 3.11) 1999 Modelled IHME
2.6 (2.03 - 3.33) 1998 Modelled IHME
2.71 (2.12 - 3.44) 1997 Modelled IHME
2.75 (2.14 - 3.50) 1996 Modelled IHME
2.78 (2.18 - 3.56) 1995 Modelled IHME
2.77 (2.16 - 3.54) 1994 Modelled IHME
2.72 (2.13 - 3.45) 1993 Modelled IHME
2.67 (2.07 - 3.40) 1992 Modelled IHME
2.6 (2.01 - 3.28) 1991 Modelled IHME
2.61 (2.01 - 3.30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
6 (4 - 8) 2019 Modelled IHME
6 (4 - 8) 2018 Modelled IHME
6 (4 - 7) 2017 Modelled IHME
5 (4 - 7) 2016 Modelled IHME
5 (4 - 7) 2015 Modelled IHME
5 (4 - 7) 2014 Modelled IHME
5 (4 - 7) 2013 Modelled IHME
5 (4 - 7) 2012 Modelled IHME
5 (4 - 7) 2011 Modelled IHME
5 (4 - 7) 2010 Modelled IHME
6 (4 - 7) 2009 Modelled IHME
6 (5 - 8) 2008 Modelled IHME
6 (5 - 8) 2007 Modelled IHME
6 (5 - 8) 2006 Modelled IHME
6 (5 - 8) 2005 Modelled IHME
6 (5 - 8) 2004 Modelled IHME
6 (5 - 8) 2003 Modelled IHME
6 (5 - 8) 2002 Modelled IHME
6 (5 - 7) 2001 Modelled IHME
6 (5 - 8) 2000 Modelled IHME
6 (5 - 8) 1999 Modelled IHME
7 (5 - 8) 1998 Modelled IHME
7 (5 - 9) 1997 Modelled IHME
7 (5 - 9) 1996 Modelled IHME
7 (6 - 9) 1995 Modelled IHME
7 (5 - 9) 1994 Modelled IHME
7 (5 - 9) 1993 Modelled IHME
7 (5 - 9) 1992 Modelled IHME
7 (5 - 8) 1991 Modelled IHME
7 (5 - 8) 1990 Modelled IHME
13 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
22 (15 - 30) 2019 Modelled IHME
22 (16 - 29) 2018 Modelled IHME
22 (16 - 29) 2017 Modelled IHME
22 (16 - 29) 2016 Modelled IHME
22 (16 - 30) 2015 Modelled IHME
22 (16 - 30) 2014 Modelled IHME
22 (16 - 30) 2013 Modelled IHME
22 (16 - 30) 2012 Modelled IHME
23 (17 - 30) 2011 Modelled IHME
23 (17 - 31) 2010 Modelled IHME
23 (17 - 31) 2009 Modelled IHME
23 (17 - 32) 2008 Modelled IHME
24 (17 - 32) 2007 Modelled IHME
24 (18 - 32) 2006 Modelled IHME
24 (18 - 32) 2005 Modelled IHME
24 (18 - 32) 2004 Modelled IHME
24 (18 - 32) 2003 Modelled IHME
24 (18 - 32) 2002 Modelled IHME
24 (18 - 32) 2001 Modelled IHME
24 (18 - 33) 2000 Modelled IHME
25 (18 - 33) 1999 Modelled IHME
25 (19 - 33) 1998 Modelled IHME
25 (19 - 33) 1997 Modelled IHME
25 (19 - 33) 1996 Modelled IHME
25 (18 - 33) 1995 Modelled IHME
25 (18 - 33) 1994 Modelled IHME
25 (18 - 33) 1993 Modelled IHME
25 (18 - 33) 1992 Modelled IHME
25 (18 - 33) 1991 Modelled IHME
25 (18 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
94 2014 Survey/reported WHO/UNICEF
91 2013 Survey/reported WHO/UNICEF
87 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
86 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
85 2008 Survey/reported WHO/UNICEF
93 2007 Survey/reported WHO/UNICEF
84 2006 Survey/reported WHO/UNICEF
92 2005 Survey/reported WHO/UNICEF
93 2004 Survey/reported WHO/UNICEF
91 2003 Survey/reported WHO/UNICEF
66 2002 Survey/reported WHO/UNICEF
18 2001 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
Source: MPP
HepB birth dose policy
No
Source: WHO
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.78 (1.45 - 2.19) 2019 Modelled IHME
1.77 (1.46 - 2.17) 2018 Modelled IHME
1.76 (1.44 - 2.17) 2017 Modelled IHME
1.74 (1.42 - 2.12) 2016 Modelled IHME
1.72 (1.39 - 2.12) 2015 Modelled IHME
1.71 (1.39 - 2.11) 2014 Modelled IHME
1.7 (1.39 - 2.10) 2013 Modelled IHME
1.7 (1.38 - 2.10) 2012 Modelled IHME
1.69 (1.38 - 2.10) 2011 Modelled IHME
1.69 (1.37 - 2.10) 2010 Modelled IHME
1.7 (1.38 - 2.11) 2009 Modelled IHME
1.7 (1.39 - 2.10) 2008 Modelled IHME
1.7 (1.39 - 2.11) 2007 Modelled IHME
1.71 (1.40 - 2.12) 2006 Modelled IHME
1.72 (1.41 - 2.13) 2005 Modelled IHME
1.72 (1.41 - 2.14) 2004 Modelled IHME
1.73 (1.41 - 2.15) 2003 Modelled IHME
1.74 (1.42 - 2.15) 2002 Modelled IHME
1.75 (1.43 - 2.15) 2001 Modelled IHME
1.75 (1.43 - 2.17) 2000 Modelled IHME
1.75 (1.42 - 2.16) 1999 Modelled IHME
1.75 (1.42 - 2.15) 1998 Modelled IHME
1.75 (1.42 - 2.16) 1997 Modelled IHME
1.75 (1.41 - 2.15) 1996 Modelled IHME
1.74 (1.41 - 2.16) 1995 Modelled IHME
1.74 (1.41 - 2.15) 1994 Modelled IHME
1.75 (1.42 - 2.17) 1993 Modelled IHME
1.75 (1.42 - 2.17) 1992 Modelled IHME
1.75 (1.42 - 2.17) 1991 Modelled IHME
1.75 (1.42 - 2.18) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.82 (2.74 - 5.18) 2019 Modelled IHME
3.65 (2.66 - 4.86) 2018 Modelled IHME
3.54 (2.64 - 4.70) 2017 Modelled IHME
3.46 (2.58 - 4.57) 2016 Modelled IHME
3.4 (2.55 - 4.52) 2015 Modelled IHME
3.35 (2.56 - 4.37) 2014 Modelled IHME
3.26 (2.52 - 4.20) 2013 Modelled IHME
3.21 (2.50 - 4.12) 2012 Modelled IHME
3.19 (2.49 - 4.06) 2011 Modelled IHME
3.17 (2.48 - 4.04) 2010 Modelled IHME
3.15 (2.45 - 4.01) 2009 Modelled IHME
3.19 (2.46 - 4.03) 2008 Modelled IHME
3.18 (2.47 - 4.02) 2007 Modelled IHME
3.18 (2.47 - 4.02) 2006 Modelled IHME
3.15 (2.47 - 3.99) 2005 Modelled IHME
3.17 (2.50 - 3.98) 2004 Modelled IHME
3.16 (2.50 - 4.01) 2003 Modelled IHME
3.11 (2.45 - 3.92) 2002 Modelled IHME
3.03 (2.38 - 3.83) 2001 Modelled IHME
3.16 (2.47 - 4) 2000 Modelled IHME
3.22 (2.50 - 4.07) 1999 Modelled IHME
3.39 (2.62 - 4.29) 1998 Modelled IHME
3.49 (2.72 - 4.41) 1997 Modelled IHME
3.51 (2.74 - 4.46) 1996 Modelled IHME
3.54 (2.74 - 4.51) 1995 Modelled IHME
3.51 (2.72 - 4.46) 1994 Modelled IHME
3.46 (2.68 - 4.40) 1993 Modelled IHME
3.4 (2.62 - 4.34) 1992 Modelled IHME
3.31 (2.54 - 4.22) 1991 Modelled IHME
3.37 (2.59 - 4.32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
11 (8 - 15) 2019 Modelled IHME
11 (8 - 14) 2018 Modelled IHME
10 (8 - 14) 2017 Modelled IHME
10 (8 - 13) 2016 Modelled IHME
10 (7 - 13) 2015 Modelled IHME
10 (7 - 13) 2014 Modelled IHME
9 (7 - 12) 2013 Modelled IHME
9 (7 - 12) 2012 Modelled IHME
9 (7 - 12) 2011 Modelled IHME
9 (7 - 11) 2010 Modelled IHME
9 (7 - 11) 2009 Modelled IHME
9 (7 - 11) 2008 Modelled IHME
9 (7 - 11) 2007 Modelled IHME
9 (7 - 11) 2006 Modelled IHME
8 (7 - 11) 2005 Modelled IHME
8 (7 - 11) 2004 Modelled IHME
8 (7 - 11) 2003 Modelled IHME
8 (6 - 10) 2002 Modelled IHME
8 (6 - 10) 2001 Modelled IHME
8 (6 - 10) 2000 Modelled IHME
8 (6 - 10) 1999 Modelled IHME
9 (7 - 11) 1998 Modelled IHME
9 (7 - 11) 1997 Modelled IHME
9 (7 - 11) 1996 Modelled IHME
9 (7 - 11) 1995 Modelled IHME
9 (7 - 11) 1994 Modelled IHME
9 (7 - 11) 1993 Modelled IHME
9 (7 - 11) 1992 Modelled IHME
8 (6 - 11) 1991 Modelled IHME
9 (7 - 11) 1990 Modelled IHME
8 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (17 - 32) 2019 Modelled IHME
24 (17 - 32) 2018 Modelled IHME
25 (18 - 32) 2017 Modelled IHME
25 (18 - 32) 2016 Modelled IHME
25 (18 - 33) 2015 Modelled IHME
25 (18 - 33) 2014 Modelled IHME
25 (18 - 33) 2013 Modelled IHME
25 (18 - 33) 2012 Modelled IHME
26 (18 - 33) 2011 Modelled IHME
25 (18 - 33) 2010 Modelled IHME
25 (18 - 33) 2009 Modelled IHME
25 (18 - 33) 2008 Modelled IHME
25 (18 - 33) 2007 Modelled IHME
25 (18 - 33) 2006 Modelled IHME
26 (18 - 33) 2005 Modelled IHME
26 (18 - 34) 2004 Modelled IHME
26 (19 - 34) 2003 Modelled IHME
26 (19 - 34) 2002 Modelled IHME
26 (19 - 34) 2001 Modelled IHME
26 (19 - 34) 2000 Modelled IHME
26 (18 - 34) 1999 Modelled IHME
26 (18 - 34) 1998 Modelled IHME
25 (18 - 34) 1997 Modelled IHME
25 (18 - 34) 1996 Modelled IHME
25 (18 - 34) 1995 Modelled IHME
25 (18 - 34) 1994 Modelled IHME
25 (18 - 34) 1993 Modelled IHME
25 (18 - 34) 1992 Modelled IHME
25 (18 - 34) 1991 Modelled IHME
25 (17 - 34) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
Source: MPP
HepB birth dose policy
No
Source: WHO
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.43 (%)
2019
(0.35 - 0.5(%))
IHME
HCV (RNA/cAg+)
1.78 (%)
2019
(1.45 - 2.19(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
6
2019
(4 - 8)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
11
2019
(8 - 15)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.03 (%)
2019, latest modelled
(0.02 - 0.05(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources